Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
23.9 USD | +1.59% | +4.89% | -21.84% |
Jun. 03 | Intellia Therapeutics Shares Rise as NTLA-2002 Phase 1 Study Observes 98% Mean Reduction in Monthly Attack Rate | MT |
Jun. 03 | Transcript : Intellia Therapeutics, Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.84% | 2.27B | |
+44.47% | 56.65B | |
-6.72% | 39.44B | |
+39.33% | 39.03B | |
-11.17% | 26.86B | |
+13.48% | 26.75B | |
-21.32% | 19.03B | |
+0.61% | 12.28B | |
+26.16% | 12.26B | |
+27.69% | 12.04B |
- Stock Market
- Equities
- NTLA Stock
- News Intellia Therapeutics, Inc.
- JPMorgan Cuts Intellia Therapeutics' Price Target to $79 From $82, Keeps Overweight Rating